Cited by 903D Printing in Biomedical ResearchDrug-Induced Hepatotoxicity and ProtectionTissue Engineering and Regenerative Medicine

Engineered Liver Platforms for Different Phases of Drug Development

Open access
Ware, Brenton R., Khetani, Salman R.·2017·Trends in Biotechnology

Abstract

Drug-induced liver injury (DILI) remains a leading cause of drug withdrawal from human clinical trials or the marketplace. Owing to species-specific differences in liver pathways, predicting human-relevant DILI using in vitro human liver models is crucial. Microfabrication tools allow precise control over the cellular microenvironment towards stabilizing liver functions for weeks. These tools are used to engineer human liver models with different complexities and throughput using cell lines, primary cells, and stem cell-derived hepatocytes. Including multiple human liver cell types can mimic cell-cell interactions in specific types of DILI. Finally, organ-on-a-chip models demonstrate how drug metabolism in the liver affects multi-organ toxicities. In this review we survey engineered human liver platforms within the needs of different phases of drug development.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tibtech.2016.08.001

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The predictive accuracy of hepatotoxicity in animal studies is only 50%.

    “However, the predictive accuracy of hepatotoxicity in animal studies is only 50%.1,5)”

    From Cryopreservation of Hepatocyte Organoid-Derived Cells Generated from Human iPS Cells (2025) · cites this paper as [5]

    In “The Drug Development Pipeline” (page not provided), the paper says animal models are not always good predictors of human drug-induced liver injury. It does not give animal studies a 50% predictive accuracy; its <50% figure refers to the sensitivity of primary human hepatocytes in conventional culture. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 77 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Ware, B. R., & Khetani, S. R.
Affiliations
University of Illinois Chicago (US)
Corresponding author
Khetani, Salman R.
Venue
Trends in Biotechnology
Publisher
Elsevier BV
Published
2017-02
Volume
35
Issue
2
Pages
172-183
ISSN
0167-7799 (ISSN-L)
OpenAlex
W2515587277
Cited by
90
References
77
Citations by year
2026: 9 · 2025: 5 · 2024: 6 · 2023: 4 · 2022: 8 · 2021: 9 · 2020: 18 · 2019: 12 · 2018: 13 · 2017: 5 · 2016: 1
FWCI
0.73
Type
journal article
Language
en
Open access
Locations
  • Trends in biotechnology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute of Biomedical Imaging and Bioengineering (R03EB019184)
  • Division of Chemical, Bioengineering, Environmental, and Transport Systems
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
drug-induced liver injury, organ-on-a-chip, microfabrication, stem cell-derived hepatocytes, primary hepatocytes, cell-cell interactions, drug metabolism, multi-organ toxicity, drug development phases
MeSH terms
Animals, Drug Evaluation, Preclinical, Equipment Design, Humans, Liver, Organ Culture Techniques, Liver, Artificial, Tissue Engineering, Tissue Scaffolds

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review